BIOMAT Database Logo BIOMAT Database Logo

Steady-state plasma concentrations of quinidine and propranolol. 1979

M Mayersohn, and D Perrier, and P Fenster, and F I Marcus

UI MeSH Term Description Entries
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D011802 Quinidine An optical isomer of quinine, extracted from the bark of the CHINCHONA tree and similar plant species. This alkaloid dampens the excitability of cardiac and skeletal muscles by blocking sodium and potassium currents across cellular membranes. It prolongs cellular ACTION POTENTIALS, and decreases automaticity. Quinidine also blocks muscarinic and alpha-adrenergic neurotransmission. Adaquin,Apo-Quinidine,Chinidin,Quincardine,Quinidex,Quinidine Sulfate,Quinora,Apo Quinidine,Sulfate, Quinidine
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Plasma propranolol steady state concentrations in thyroid disorders.
January 1981, European journal of clinical pharmacology,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Quinidine saliva concentrations: absence of correlation with serum concentrations at steady state.
November 1983, Clinical pharmacology and therapeutics,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Cimetidine increases steady state plasma levels of propranolol.
December 1981, British journal of clinical pharmacology,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
February 1987, American heart journal,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Plasma concentrations of propranolol and 4-hydroxy-propranolol at steady-state in neurological patients: intersubject and intrasubject correlations with dose.
January 1984, International journal of clinical pharmacology research,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
[Average steady-state plasma levels with slow release quinidine preparations].
September 1979, Archives des maladies du coeur et des vaisseaux,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Plasma and saliva propafenone concentrations at steady state.
June 1987, Journal of pharmaceutical sciences,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Steady-state plasma concentrations of alprenolol in man.
August 1974, European journal of clinical pharmacology,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Steady-state plasma concentrations of propafenone--chirality and metabolism.
July 1994, International journal of clinical pharmacology and therapeutics,
M Mayersohn, and D Perrier, and P Fenster, and F I Marcus
Comparative quinidine plasma profiles at steady state of two controlled-release products and quinidine sulfate in solution.
January 1987, Biopharmaceutics & drug disposition,
Copied contents to your clipboard!